At a glance
- Confirm both tablet availability and accepted identity evidence.
- A card cannot establish whether oral semaglutide is suitable.
- Keep identity documents separate from the clinical information the prescriber needs.
Check the service before buying identification
Wegovy tablets have a UK patient leaflet covering 1.5 mg, 4 mg, 9 mg and 25 mg strengths. [1] That does not mean every service supplies tablets. Ask which exact product is offered and whether it can assess your situation before buying an ID card or paying a non-refundable fee.
Some web pages use “Wegovy” when they mean pens, while a search result may mention tablets without describing an available service. Read the product and consultation information together. If a service offers another medicine instead, ask for a separate explanation of its licence, suitability and instructions. Do not assume that any oral semaglutide product is interchangeable with the tablets you requested.
Understand what a card would achieve
A PASS-accredited card provides proof-of-age evidence through an accredited issuer. [2] It does not certify medical eligibility or prescribe a tablet. The provider decides what its identity process can accept, so obtain confirmation about the exact card and any additional checks.
If a card is accepted, ask whether you need the physical document and whether an identity contractor will be involved. If it is not accepted, ask what supported alternatives exist. Avoid spending money because a comparison page calls a document “universally accepted”. There is no single pharmacy-wide promise this guide can make on behalf of separate organisations.
Why a tablet still needs a proper consultation
Great Britain's GPhC guidance includes extra safeguards for remote weight-management prescribing, rather than relying on questionnaire answers alone. [3] Identity verification cannot show what medicines you take, how previous treatment affected you or whether a tablet routine fits your circumstances.
Make a separate list for the clinician: health conditions, other prescriptions, previous weight-management treatment, side effects and any gap in use. Mention whether you have used semaglutide injections or another oral brand. Bring questions about fasting, other morning medicines and follow-up. The assessment should decide whether treatment is suitable before the practical instructions are treated as your personal plan.
Ask for help with the actual obstacle
Explain whether you have no photo ID, cannot use a camera, have changed name, or cannot complete the online process. Ask for a clear list of accepted alternatives or an in-person route. You do not need to invent an explanation that sounds more likely to be accepted; the service needs the real problem to offer an appropriate option.
Before uploading evidence, check the provider's name, contact details and privacy notice. Ask whether the documents are needed for identity or clinical verification. This helps you submit the right information through the right channel. If you need a carer to help, ask the service how it handles assistance and consent rather than sharing an account informally.
Check the provider and plan the next step
Check the GPhC pharmacy register for Great Britain. [7] Inspection reports provide separate information about the pharmacy. [4] For Northern Ireland, use the PSNI register. [5] Northern Ireland has its own online-seller arrangements through the MHRA. [6] A logo copied onto a sales page is not a substitute for matching the actual pharmacy details.
Ask who will prescribe and dispense, how reviews work and how to report a problem. Keep the identity policy and any fee information. If the service cannot complete a supported assessment, ask a known pharmacist or GP about other options. Do not move to a seller promising immediate tablets without a prescription. Resolving an access barrier should lead to proper care, including a way to get help after the first pack arrives.
Questions and answers
Can a PASS card prove I meet the prescribing criteria?
No. It may contribute to an accepted identity process. Clinical information and a prescribing decision are still needed. [3]
Does the tablet licence mean any online seller is legitimate?
No. Verify the service and dispensing pharmacy independently, confirm the exact medicine and expect an appropriate clinical assessment.
Sources
Sources consulted for this editorial update: 28 October 2026. Follow the link for the source’s own revision date.
- Wegovy tablets: UK patient leafletUK 1.5 mg, 4 mg, 9 mg and 25 mg tablets; leaflet revised June 2026.
- PASS: National Proof of Age Standards SchemeAccreditation of proof-of-age card issuers; not medicine authorisation.
- GPhC: distance pharmacy guidance, February 2025Great Britain requirements for remote services and extra prescribing safeguards.
- GPhC: pharmacy inspectionsReports for pharmacies in Great Britain.
- PSNI: search the registerPharmacy and pharmacist registration in Northern Ireland.
- MHRA: authorised online medicine sellers in Northern IrelandNorthern Ireland online seller register and distance-selling logo distinction.
- GPhC: pharmacy registerDirect current-registration lookup for pharmacies in England, Scotland and Wales; inspection reports are separate.
This page is general information for UK readers. It cannot tell you which medicine or dose is suitable for you. Read the scope and limits.